|
|
Article: Findings in hypertension reported from Istanbul University.(Report)
- Article from:
- Blood Weekly
- Article date:
- April 2, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
According to recent research published in the Journal of Human Hypertension, "The Gemini-AALA (Australia, Asia, Latin America, Africa/Middle East) study evaluated the efficacy and safety of single-pill amlodipine/atorvastatin (Caduet) for the treatment of patients of diverse ethnicity with concomitant hypertension and dyslipidaemia. This was a 14-week, open-label study including patients from 27 countries across the Middle East, Asia-Pacific, Africa and Latin America."
"Eight dosage strengths of single-pill amlodipine/atorvastatin (5/10, 10/10, 5/20, 10/20, 5/40, 10/40, 5/80 and 10/80 mg) were titrated to improve blood pressure and lipid control. Blood pressure ...
Related newspaper, magazine, and journal articles:
|
|
Article: Reports from Istanbul University highlight recent ...
Information Technology Newsweekly;
July 21, 2008 ;
700+ words
..."Istanbul University faculty were surveyed to examine ... Dilekkayaoglu and colleagues, Istanbul University. The researchers concluded ... electronic journals by faculty at Istanbul University, Turkey: The results of a ...
|
|